SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-135877
Filing Date
2020-12-15
Accepted
2020-12-15 19:25:24
Documents
1
Period of Report
2020-12-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2038482-4_3.html 3  
1 OWNERSHIP DOCUMENT tm2038482-4_3.xml 3 7778
  Complete submission text file 0001104659-20-135877.txt   9213
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Issuer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 71 LANTERN RIDGE RD NEW CANAAN CT 06840
Business Address
Gibson Robert J (Reporting) CIK: 0001821615 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39788 | Film No.: 201390871